Guofeng Meng is a seasoned scientist with experience in drug discovery and genomic research. At GSK from May 2014 to September 2017, Guofeng focused on drug discovery for neurological diseases. Prior to this, Guofeng served as a postdoctoral researcher at the Max Planck Institute for Molecular Genetics from September 2011 to May 2014, where the work involved predicting transcriptional regulation in breast cancer and analyzing NGS data for the DEEP project. Currently, Guofeng holds the position of Staff Scientist at a Johnson & Johnson subsidiary since October 2017. Guofeng earned a Doctor of Philosophy (Ph.D.) in Biomathematics, Bioinformatics, and Computational Biology from the Partner Institute of Computational Biology, completing the degree in 2011.
This person is not in the org chart
This person is not in any teams
This person is not in any offices